Depression, Anxiety and Sleep in Parkinson's Disease (NCT07622303) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Depression, Anxiety and Sleep in Parkinson's Disease
100 participantsStarted 2026-06-01
Plain-language summary
This study aims to assess the prevalence and severity of depression, anxiety, and sleep disorders among patients with idiopathic Parkinson's disease. The study will evaluate the relationship between neuropsychiatric symptoms and disease characteristics in order to improve early recognition and patient quality of life.
Who can participate
Age range
50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients diagnosed with idiopathic Parkinson's disease according to the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease (Postuma et al., 2015).
. Age ≥ 50 years.
. Ability to understand and respond to questionnaires and rating scales.
. Ability and willingness to provide informed consent.
Exclusion criteria
. Patients with atypical parkinsonism.
. Patients with a history of other major neurological disorders (e.g., stroke, Alzheimer's disease, multiple sclerosis).
. Patients with severe cognitive impairment or dementia that prevents reliable completion of rating scales.
. Patients with a current diagnosis of severe psychiatric disorders unrelated to 5-Parkinson's disease (e.g., schizophrenia, bipolar disorder).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Assessment of Depression Severity in Patients with idiopathic Parkinson's Disease
Timeframe: Baseline assessment during study enrollment.
2
Assessment of Anxiety Severity in Patients with idiopathic Parkinson's Disease
Timeframe: Baseline
3
Assessment of Sleep Disturbance in Patients with idiopathic Parkinson's Disease